Synthesis and spectral characterization of Schiff base complexes of Cu(II), Co(II), Zn(II) and VO(IV) containing 4-(4-aminophenyl)morpholine derivatives: antimicrobial evaluation and anticancer studies

Metal(II) chelates of Schiff bases derived from the condensation of 4-morpholinoaniline with substituted salicylaldehyde have been prepared and characterized by (1)H NMR, IR, electronic, EPR, and magnetic measurement studies. The complexes are of the type M(X-MPMP)2 [where M=Cu(II), Co(II)), Zn(II), or VO(IV); MPMP=2-[(4 morpholinophenyl imino) methyl] 4-X-phenol, X=Cl, (L1H), X=Br (L2H)]. Single crystal X-ray crystallography studies confirm the structure of newly synthesized Schiff bases. The Schiff bases act as bidentate monobasic ligands, coordinating through deprotonated phenolic oxygen and azomethine nitrogen atoms. The free ligands and metal complexes are screened for their biopotency. Metal complexes exhibit better activity than ligands. Anticancer activity of ligands and their metal complexes are evaluated in human heptocarcinoma(HepG2) cells. The preliminary bioassay indicates that the Schiff base and its zinc complex exhibit inhibitory activity against the human gastric cancer cell lines.

Metal based new triazoles: their synthesis, characterization and antibacterial/antifungal activities

A series of new triazoles and their oxovanadium(IV) complexes have been synthesized, characterized and evaluated for antibacterial/antifungal properties. The new Schiff bases ligands (L(1))-(L(5)) were prepared by the condensation reaction of 3,5-diamino-1,2,4-triazole with 2-hydroxy-1-naphthaldehyde, pyrrole-2-carboxaldehyde, pyridine-2-carboxaldehyde, 2-acetyl pyridine and 2-methoxy benzaldehyde. The structures of the ligands have been established on the basis of their physical, spectral (IR, (1)H and (13)C NMR and mass spectrometry) and elemental analytical data. The prepared ligands were used to synthesize their oxovanadium(IV) complexes (1)-(5) which were also characterized by their physical, spectral and analytical data and proposed to have a square pyramidal geometry. The ligands and their complexes were screened for in vitro antibacterial activity against six bacterial species such as, Escherichia coli, Shigella flexneri, Pseudomonas aeruginosa, Salmonella typhi, Staphylococcus aureus, and Bacillus subtilis and for in vitro antifungal activity against six fungal strains, Trichophyton longifusus, Candida albicans, Aspergillus flavus, Microsporum canis, Fusarium solani, and Candida glabrata. Cytotoxic nature of the compounds was also reported using brine shrimp bioassay method against Artemia salina.

Ligating behaviour of Schiff base ligands derived from heterocyclic beta-diketone and ethanol or propanol amine with oxovanadium (IV) metal ion

Synthesis and evaluation of six new oxovanadium (IV) complexes, formed by the interaction of vanadyl sulphate pentahydrate and the Schiff base, viz.; (HL(1))-(HL(3)) and (HL(4))-(HL(6)) such as 5-hydroxy-3-methyl-1(2-chloro)phenyl-1H-pyrazolone-4-carbaldehyde (I), 5-hydroxy-3-methyl-1(3-chloro)phenyl-1H-pyrazolone-4-carbaldehyde (II) and 5-hydroxy-3-methyl-1(3-sulphoamido)phenyl-1H-pyrazolone-4-carbaldehyde (III) with ethanol amine and propanol amine, respectively, in aqueous ethanol medium. The ligands and their Schiff base ligands have been characterized by elemental analyses, IR and (1)H NMR. The resulting complexes have been characterized by elemental analyses, IR, (1)H NMR, mass, electronic, electron spin resonance spectra, magnetic susceptibility measurement, molar conductance and thermal studies. The IR spectral data suggest that the ligand behaves as a dibasic bidentate with ON donor sequence towards metal ion. The molar conductivity data show them to be non-electrolytes. From the electronic, magnetic and ESR spectral data suggest that all the oxovanadium (IV) complexes have distorted octahedral geometry.